Clinical Trials Directory

Trials / Unknown

UnknownNCT06293885

Pleurodesis Using Hypertonic Glucose

PLeurodesis Using Hypertonic Glucose Administration to Treat Post-operative Air Leaks Following Lung Resection Surgery (PLUG): Phase II Randomized Feasibility Trial

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Air leaks from unhealed lung tissue following lung resection for benign or malignant lesions are one of the most common complications following thoracic surgery, occurring after 10% of major lung resections. The purpose of this study is to investigate the efficacy of intrapleural administration of Dextrose 50% to resolve air leaks after pulmonary resection.

Conditions

Interventions

TypeNameDescription
DRUGDextrose 50a solution of 50% glucose (D50) will be injected into your pleural space
OTHERStandard of Care - No Dextrose 50Standard of Care

Timeline

Start date
2024-03-30
Primary completion
2025-04-30
Completion
2025-04-30
First posted
2024-03-05
Last updated
2024-03-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06293885. Inclusion in this directory is not an endorsement.